The Human Phenotype Ontology in 2017

Deep phenotyping has been defined as the precise and comprehensive analysis of phenotypic abnormalities in which the individual components of the phenotype are observed and described. The three components of the Human Phenotype Ontology (HPO; www.human-phenotype-ontology.org) project are the phenotype vocabulary, disease-phenotype annotations and the algorithms that operate on these. These components are being used for computational deep phenotyping and precision medicine as well as integration of clinical data into translational research. The HPO is being increasingly adopted as a standard for phenotypic abnormalities by diverse groups such as international rare disease organizations, registries, clinical…

• UD
  U.S. Department of Energy

  Awards: -AC02-05CH11231, 05CH11231, R24-OD011883, AC02-05CH11231, DE-AC02, DE-AC02-05CH11231, DE-AC02-
• CS
  Cold Spring Harbor Laboratory
• NB
  NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
• E
  E-Rare
• NI
  National Institute for Health and Care Research

  Award: FP7/2007-2013
• EC
  European Commission

  Awards: 305608, 305444, 2012-305121, FP7/2007-2013, DE-AC02-05CH11231, 2007-2013, FP7/2007, 2012-305608, 305121
• ES
  European Science Foundation

  Award: HE5415/3-1
• DF
  Deutsche Forschungsgemeinschaft

  Awards: DE-AC02-05CH11231, HE5415/6-1, FP7/2007-2013, HE5415/3-1, HE5415/5-1
• BF
  Bundesministerium für Bildung und Forschung

  Awards: 0313911, 01DH12033
• ME
  Moorfields Eye Hospital NHS Foundation Trust
• NI
  National Institutes of Health

  Awards: FP7/2007-2013, 5R24OD011883, NIH OD #5R24OD011883, DE-AC02-05CH11231, OD #5R24OD011883
• OO
  Office of Science

  Awards: AC02-05CH11231, -AC02-05CH11231, DE-AC02
• UN
  U.S. National Library of Medicine
• BE
  Basic Energy Sciences

  Awards: DE-AC02, AC02-05CH11231, DE-AC02-05CH11231, -AC02-05CH11231